Earlier in the COVID-19 pandemic, treatment recommendations for COVID-19 were scattered with new data pouring in. As new treatments were tested, their efficacies were revealed and national guideline recommendations were made accordingly. Given the number of potential treatments, it is essential for clinicians to know the guidelines to treat their patients effectively and prevent poor outcomes. This is the second of three modules on the outpatient management of patients with COVID-19. The focus of this module is on treatment of mild-to-moderate COVID-19.
At the conclusion of this activity, the PA should be better able to:
Incorporate knowledge of national treatment guidelines to the management of patients with COVID-19
Acknowledgment of Commercial Support
Supported by an independent educational grant from Pfizer Inc.